MICHAEL WHITE to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications MICHAEL WHITE has written about Xenograft Model Antitumor Assays.
Connection Strength
0.254
-
Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov. 2017 08; 7(8):832-851.
Score: 0.112
-
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer. Nature. 2016 Oct 06; 538(7623):114-117.
Score: 0.107
-
An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis. Neoplasia. 2020 08; 22(8):294-310.
Score: 0.034